Our findings showed that the upregulation of NFE2L2 expression level predicted the risk of CIN with 96% sensitivity and 100% specificity, and could be a biomarker for the diagnosis of early stages of CIN. The gene discussed is NFE2L2; the disease is cervical squamous intraepithelial neoplasia.